CASI Pharmaceuticals
CASI
#10193
Rank
NZ$27.14 M
Marketcap
NZ$1.32
Share price
4.16%
Change (1 day)
-68.60%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2025 (TTM): -NZ$81.48 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are NZ$26.84 Million. In 2024 the company made an earning of -NZ$63.79 Million a decrease over its 2023 earnings that were of -NZ$44.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$81.48 Million27.73%
2024 -NZ$63.79 Million44.35%
2023 -NZ$44.19 Million-29.55%
2022 -NZ$62.72 Million4.43%
2021 -NZ$60.05 Million-24.56%
2020 -NZ$79.6 Million4.74%
2019 -NZ$76 Million65.13%
2018 -NZ$46.03 Million155.07%
2017 -NZ$18.05 Million13.93%
2016 -NZ$15.84 Million31.18%
2015 -NZ$12.08 Million-72.5%
2014 -NZ$43.9 Million356.62%
2013 -NZ$9.62 Million-60.55%
2012 -NZ$24.37 Million218.41%
2011 -NZ$7.66 Million0.74%
2010 -NZ$7.6 Million-32.54%
2009 -NZ$11.27 Million-66.98%
2008 -NZ$34.11 Million-14.22%
2007 -NZ$39.76 Million7.04%
2006 -NZ$37.15 Million27.95%
2005 -NZ$29.04 Million4.51%
2004 -NZ$27.78 Million-15.84%
2003 -NZ$33.01 Million-55.29%
2002 -NZ$73.83 Million-34.05%
2001 -NZ$0.12 Billion31.73%
2000 -NZ$84.98 Million31.56%
1999 -NZ$64.6 Million145.56%
1998 -NZ$26.31 Million76.4%
1997 -NZ$14.92 Million36.92%
1996 -NZ$10.9 Million